Insulet



Ebitda تغيير تاريخ
Abbott USD 2.66B 265M 2024-12
Align Technology USD 215.22M 15.06M 2024-12
AtriCure USD -9697000 7.22M 2024-12
Avanos Medical USD 28.6M 2M 2024-12
Baxter International USD 576M 116M 2024-12
Becton, Dickinson and Co. USD 1.25B 339M 2024-12
Boston Scientific USD 1.37B 125M 2024-12
Cardinal Health USD 758M 19M 2024-12
Cooper Companies USD 243.8M 45.6M 2025-01
Dexcom USD 305.3M 98M 2024-12
Edwards Lifesciences USD 396M 32.4M 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Globus Medical USD 145.33M 29.19M 2024-12
ICU Medical USD 100.77M 19.72M 2024-12
Insulet USD 130.8M 21.4M 2024-12
Integra LifeSciences USD 104.98M 43.09M 2024-12
J&J USD 6.12B 1.51B 2024-12
Masimo USD -25600000 79.7M 2024-12
Medtronic USD 2.44B 134M 2025-01
Merit Medical Systems USD 76.66M 10.02M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Solventum Corp 483M 75M 2024-12
Stryker USD 1.93B 473M 2024-12
Tandem Diabetes Care USD 3.66M 25.54M 2024-12
Teleflex USD 212.6M 224K 2024-12
West Pharmaceutical Services USD 208.6M 4.5M 2024-12
Zimmer Biomet Holdings USD 709.4M 138.6M 2024-12



Insulet - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.